KajiiT, OhamaK.Androgenetic origin of hydatidiform mole. Nature1977;268:633–634.
2.
ZaragozaMV, SurtiU, RedlineRW, MillieE, ChakravartiA, HassoldTJ. Parental origin and phenotype of triploidy in spontaneous abortions: predominance of diandry and association with the partial hydatidiform mole. Am J Hum Genet2000;66:1807–1820.
3.
ZaragozaMV, KeepD, GenestDR, HassoldT, RedlineRW. Early complete hydatidiform moles contain inner cell mass derivatives. Am J Med Genet1997;70:273–277.
4.
Lambert-MesserlianG, PinarH, RubinLP, Second trimester maternal serum markers in twin pregnancy with complete mole: report of two cases. Pediatr Dev Pathol2005;8.
5.
StellerMA, GenestDR, BernsteinMR, LageJM, GoldsteinDP, BerkowitzRS. Clinical features of multiple conception with partial or complete molar pregnancy and coexisting fetuses. J Reprod Med1994;39:147–154.
6.
ParadinasFJ, SebireNJ, FisherRA, Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles. Histopathology2001;39:447–454.
7.
JauniauxE.Partial moles: from postnatal to prenatal diagnosis. Placenta1999;20:379–388.
8.
SebireNJ, FoskettM, ParadinasFJ, Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin. Lancet2002;359:2165–2166.
9.
WaldNJ, HuttlyWJ, HackshawAK. Antenatal screening for Down's syndrome with the quadruple test. Lancet2003;361:835–836.
10.
FlorioP, SeveriFM, CobellisL, Serum activin A and inhibin A. New clinical markers for hydatidiform mole. Cancer2002;94:2618–2622.
11.
PautierP, GhioneS, Brailly-TabardS, LhommeC, MoriceP, BidartJM. Are serum inhibin concentrations new markers of placental tumours in the course of chemotherapy?Hum Reprod2001;16:2434–2437.
12.
KatoT, SekiK, MatsuiH, SekiyaS.Circulating inhibin forms in patients with hydatidiform mole. Gynecol Obstet Invest2002;54:114–117.
